Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Eph Receptor tyrosine Kinase A2 (EPHA2) antibody

Antigen

Eph Receptor tyrosine Kinase A2 (EPHA2)

Clonality Monoclonal (Kalpha-5H5)
Host

Mouse

Reactivity

Human

Application
Flow Cytometry (FACS), Cell-ELISA (cELISA), Immunofluorescence (IF)
4 references available
Catalog no. ABIN179724
Quantity 100 ug  (2 mg/ml)
Price 594.29 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 3 to 5 Business Days

Additional Information

Alternative name Eph receptor tyrosine kinase A2 (EphA2)
Immunogen genetic immunisation with cDNA encoding human EphA2
Format Purified
Isotype IgG1  (Matching secondary antibodies)
Clone Kalpha-5H5
Description EphA2 (Eph receptor tyrosine kinase A2) belongs to the Eph tyrosine receptor familiy, the largest receptor tyrosine kinase family of transmembrane proteins. It encodes a 130 kDA transmembrane protein which is primarily found in adult human epithelial cells (1). Eph receptors and their ephrin ligands are important mediators of cell-cell communication and play roles in embryonic patterning, neuronal targeting, and vascular development during normal embryogenesis (2,3). The Eph family of receptor tyrosine kinases is frequently overexpressed in a wide variety of cancers and tumor cell lines. In particular, EphA2 is overexpressed in prostate, lung and colon cancers and 40% of breast cancers and it represent an attractive potential target for drug design (3,4).
Specificity Anti-human EphA2

Application Details

Application Notes FACS: 1.2ug/10^6 cells, Cell-ELISA: 1:200 to 1:400, Immunofluorescence: 1 ug/10^6 cells
Concentration 2 mg/ml
Purification Protein G
Buffer phosphate buffered saline, pH 7.2
Storage Short term: 2°C - 8°C. long term: -20°C (avoid repeated freezing and thawing)
Restrictions For Research Use only

Publications

Publications Lindberg, Hunter: "cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases." in: Molecular and cellular biology, Vol. 10, Issue 12, pp. 6316-24, 1991 (PubMed).

Nakamoto, Bergemann: "Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis." in: Microscopy research and technique, Vol. 59, Issue 1, pp. 58-67, 2002 (PubMed).

Brantley-Sieders, Schmidt, Parker et al.: "Eph receptor tyrosine kinases in tumor and tumor microenvironment." in: Current pharmaceutical design, Vol. 10, Issue 27, pp. 3431-42, 2004 (PubMed).

Ireton, Chen: "EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics." in: Current cancer drug targets, Vol. 5, Issue 3, pp. 149-57, 2005 (PubMed).